Search results
Homepage | Pfizer Singapore. Science Contact Us. Breakthroughs that Change Patients' Lives Pfizer Colleagues Work to Challenge the Mos t Feared Diseases of Our Time Learn More Coronavirus Resources Current information on our scientific progress Learn More Innovative Therapies for Tomorrow Translating advanced science and technologies into ...
- Our Purpose
Our Purpose Home Our Purpose. At Pfizer Singapore, w e are...
- Our Products
Every day, Pfizer colleagues work across developed and...
- Our Science
At Pfizer our biotechnology is our foundation. With 25,000...
- About Pfizer
Home Our Purpose About Pfizer About Us. Every day, Pfizer...
- Careers
At Pfizer, we’re driven to discover the cure - driven to...
- Contact Us
Connect with Us Thank you for your interest in Pfizer...
- News Articles
Home News Biopharma Leaders Unite to Stand with Science...
- Focus Areas
Focus Areas. We create revolutionary medicines across all...
- Our Purpose
At Pfizer, we’re driven to discover the cure - driven to significantly improve the lives of everyone, everywhere. If you’re similarly driven, you’ll find there’s no better place to begin (and continue) your career than at Pfizer.
Scientific and Laboratory Services (SLS) Singapore supports PGS by providing reference standards to Pfizer’s global network and our partners. We procure, establish, maintain and distribute reference standards required for release, stability and QC testing for more than 1,000 small molecules and focus on materials which are not commercially ...
Oct 28, 2023 · 28th Oct 2023. The Expert Committee on COVID-19 Vaccination (EC19V) recommends that the Pfizer-BioNTech/Comirnaty and Moderna/Spikevax vaccines used for COVID-19 vaccination in Singapore are updated to their latest versions based on the Omicron XBB.1.5 variant, as they become available.
- Rolling Data Submission For Speedier Evaluation
- Vaccine Safety and Efficacy
- Continuous Review of Data
- Active Vaccine Safety Monitoring
4 The Pfizer-BioNTech COVID-19 vaccine was granted interim authorisation under the Pandemic Special Access Route (PSAR). This regulatory pathway facilitates access to critical novel vaccines, medicines and medical devices during a pandemic such as the current COVID-19 pandemic. 5 Using PSAR, HSA can start evaluating new vaccines, medicines and medi...
9 HSA’s review of the available clinical data found that the benefits of the Pfizer-BioNTech COVID-19 vaccine outweigh the known risks. The vaccine demonstrated a high vaccine efficacy of 95%. This means that there is a 95% reduction of symptomatic COVID-19 disease in a vaccinated group of people as compared to a similarly sized group of unvaccinat...
11 As a condition for the interim authorisation under PSAR, Pfizer and BioNTech are required to monitor the longer term efficacy of the vaccine to determine the duration of protection against COVID-19. This will augment the available data which shows that the vaccine continues to be effective for at least 2 months, with no signs of waning protectio...
17 As with all other vaccines, some rare side effects may not be known at the time of HSA’s authorisation and may only occur after the vaccine is used over a longer period of time and in much larger, diverse groups of people. HSA will conduct post-market monitoring of the Pfizer-BioNTech Covid-19 vaccine to ensure that it continues to be safe for u...
Dec 30, 2020 · The Pfizer-BioNTech COVID-19 vaccine has been reviewed and endorsed for use in Singapore for individuals aged 16 and above. [Updated 3 Feb 2021] The Moderna COVID-19 vaccine has been authorised for use in Singapore. Details here.
Sep 15, 2023 · The Health Sciences Authority (HSA) has on 12 September 2023 authorised the updated Comirnaty vaccine by Pfizer to be used in Singapore for the prevention of Coronavirus Disease 2019 (COVID-19) in individuals aged 6 months and above.
